To identify genes influencing age at onset (AAO) in two common neurodegenerative diseases, we performed a genomic screen for AAO in families with Alzheimer disease (AD;) and Parkinson disease (PD. (Li et al, AJHG, April, 2002). Heritabilities between 40 percent-60 percent were found in both the AD and PD datasets. For PD, significant evidence for linkage to AAO was found on chromosome 1p (LOD =3.41). In addition, evidence for AAO linkage on chromosomes 6 and 10 was identified independently in both the AD and PD data sets. Subsequent unified analyses of these regions identified a single peak on chromosome 10q between D10S 1239 and D10S 1237, with a maximum LOD score of 2.62. These data suggest that a common gene affects AAO in these two common complex neurodegenerative diseases. We propose to further map and identify the genes contributing to this age-of-onset effect. We will continue to collect new AD and PD families to further map the peaks, and test candidate genes within the region for association to age of onset in these two disorders. Candidates will be prioritized using initially obvious biological candidates, then candidates that lie within the linkage peaks that are identified through Serial Analysis of Gene Expression and Microarray studies in both AD and PD (being performed in our lab in concurrent studies) and finally through fine mapping of the linkage peak for high areas of association using a DNA pooling approach and a new Single base pair- denaturing high performance liquid chromatography methodology. Candidates lying within these high association areas will be investigated further. Once identified, the genes will be investigated in collaboration with known mouse models, at present the Parkin model of Dr. Jian Feng and the APOE models of Dr. Don Schmechel of the DUMC Alzheimer Disease Research Center. Identifying age-of-onset genes may lead to treatment and delay of these late-onset disorders and a better understanding of the pathological processes they share.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
7R01NS031153-14
Application #
7178445
Study Section
Special Emphasis Panel (ZRG1-EDC-3 (01))
Program Officer
Sieber, Beth-Anne
Project Start
1997-02-20
Project End
2010-01-31
Budget Start
2007-02-01
Budget End
2010-01-31
Support Year
14
Fiscal Year
2007
Total Cost
$520,878
Indirect Cost
Name
University of Miami School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Lambert, Jean-Charles; Sleegers, Kristel; González-Pérez, Antonio et al. (2010) The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis 22:247-55
Beecham, Gary W; Naj, Adam C; Gilbert, John R et al. (2010) PCDH11X variation is not associated with late-onset Alzheimer disease susceptibility. Psychiatr Genet 20:321-4
Beecham, Gary W; Martin, Eden R; Gilbert, John R et al. (2010) APOE is not associated with Alzheimer disease: a cautionary tale of genotype imputation. Ann Hum Genet 74:189-94
Naj, Adam C; Beecham, Gary W; Martin, Eden R et al. (2010) Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet 6:e1001130
Beecham, Gary W; Martin, Eden R; Li, Yi-Ju et al. (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet 84:35-43
Slifer, Michael A; Martin, Eden R; Gilbert, John R et al. (2009) Resolving the relationship between ApolipoproteinE and depression. Neurosci Lett 455:116-9
Beecham, Gary W; Schnetz-Boutaud, Nathalie; Haines, Jonathan L et al. (2009) CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet 73:379-81
Xu, Pu-Ting; Li, Yi-Ju; Qin, Xue-Jun et al. (2007) A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci 36:313-31
Xu, Pu-Ting; Li, Yi-Ju; Qin, Xue-Jun et al. (2006) Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis 21:256-75
Ercoli, Linda; Siddarth, Prabha; Huang, Sung-Cheng et al. (2006) Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease. Arch Gen Psychiatry 63:442-8

Showing the most recent 10 out of 47 publications